H4D
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | 2.1m | 2.4m | 2.4m | 2.2m |
% growth | - | 163 % | 17 % | - | - |
Profit | (3.2m) | (5.0m) | - | - | - |
% profit margin | (408 %) | (245 %) | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | - | ||
* | €6.7m | Series B | |
* | €15.0m | Late VC | |
Total Funding | €21.7m |
Related Content
Recent News about H4D
EditH4D operates in the telemedicine and teleconsultation sector, providing innovative solutions to facilitate access to healthcare. The company's core product is the Consult Station, a connected medical booth that allows for high-quality medical teleconsultations. H4D serves a diverse range of clients, including citizens, government workers, pharmacies, healthcare facilities, senior and student residences, and occupational health services. The company operates primarily in the European market but also complies with U.S. FDA regulations, indicating a broader market reach. H4D's business model revolves around selling and leasing its telemedicine booths, along with offering comprehensive support services for building medical projects. Revenue is generated through the sale of these booths, subscription services for teleconsultations, and maintenance contracts. The company aims to improve employee health, enhance the quality of work life, and strengthen employer brands by providing premium health services. H4D is committed to maintaining high standards, as evidenced by its compliance with EN ISO 13485:2016 and FDA regulations. The company has also raised significant funding to further revolutionize access to healthcare.
Keywords: telemedicine, teleconsultation, medical booth, healthcare access, occupational health, pharmacies, senior residences, student residences, quality management, FDA compliance.